BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 27716428)

  • 1. Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report.
    Schiavoni M; Coluccia A
    J Med Case Rep; 2016 Oct; 10(1):276. PubMed ID: 27716428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recanalization of lower-limb deep veins as an index of efficacy of treatment for acute venous thrombosis].
    Kuznetsov MR; Sapelkin SV; Boldin BV; Leont'ev SG; Neskhodimov LA
    Angiol Sosud Khir; 2016; 22(3):82-8. PubMed ID: 27626254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
    Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
    Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report.
    Zolfaghari Emameh R; Heshmatnia J
    J Med Case Rep; 2023 Mar; 17(1):101. PubMed ID: 36934279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin.
    de Athayde Soares R; Matielo MF; Brochado Neto FC; Nogueira MP; Almeida RD; Sacilotto R
    Surgery; 2019 Dec; 166(6):1076-1083. PubMed ID: 31277885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin resistance due to sulfasalazine.
    Teefy AM; Martin JE; Kovacs MJ
    Ann Pharmacother; 2000 Nov; 34(11):1265-8. PubMed ID: 11098339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of life of patients with venous thromboses in different variants of anticoagulant therapy].
    Kalinin RE; Suchkov IA; Pshennikov AS; Agapov AB
    Angiol Sosud Khir; 2016; 22(2):15-20. PubMed ID: 27336328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs.
    Park JK; Koo do H; Yoon DH; Lee JN
    Ann Vasc Surg; 2016 Jul; 34():119-34. PubMed ID: 27177705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin.
    Houghton DE; Lekah A; Macedo TA; Hodge D; Saadiq RA; Little Y; Casanegra AI; McBane RD; Wysokinski WE
    J Thromb Thrombolysis; 2020 Feb; 49(2):199-205. PubMed ID: 31422520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasound dynamics lysis apex thrombus as an objective criterion of effectiveness of anticoagulation therapy in venous thrombosis].
    Kalinin RE; Suchkov IA; Pshennikov AS; Agapov AB
    Khirurgiia (Mosk); 2016; (2):61-65. PubMed ID: 26977870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment.
    Vítovec M; Golán L; Roztocil K; Linhart A
    Vasa; 2009 Aug; 38(3):238-44. PubMed ID: 19736635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
    Siegmund HU; Burghaus R; Kubitza D; Coboeken K
    Br J Clin Pharmacol; 2015 Jun; 79(6):959-66. PubMed ID: 25510952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report.
    Scarano M; Casale M; Mantini C; Imbalzano E; Consorti C; Clemente D; Dattilo G
    J Med Case Rep; 2017 Apr; 11(1):97. PubMed ID: 28390428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
    Anderson DR; Wilson SJ; Blundell J; Petrie D; Leighton R; Stanish W; Alexander D; Robinson KS; Burton E; Gross M
    J Bone Joint Surg Am; 2002 Nov; 84(11):1992-7. PubMed ID: 12429760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.
    Merli GJ; Hollander JE; Lefebvre P; Laliberté F; Raut MK; Germain G; Bookhart B; Pollack CV
    J Med Econ; 2016; 19(1):84-90. PubMed ID: 26390315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
    Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
    Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Phlegmasia Cerulea Dolens After Warfarin Reversal for Acute Rectal Bleeding: A Case Report.
    Fong B; Novak D; Dalley M; Alfred G
    J Emerg Med; 2018 Apr; 54(4):533-536. PubMed ID: 29449120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.